| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by LCS.
Page 2: 1 2 3 4 5 6 7 8 9
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 301 | 33 | 37 | 2157 2002 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 130(1):75-84 Marriott JB; Clarke IA; Dredge K; Muller G; Stirling D; Dalgleish AG Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during co-stimulation of both CD4(+) and CD8(+) T cells | 15 | 17 |
| 302 | 0 | 5 | 95 1962 COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES 156(5):765-& GIROUD A; MERCIERPAROT L; TUCHMANNDUPLESS.H OBSERVATIONS SUR LES REPERCUSSIONS TERATOGENES DE LA THALIDOMIDE CHEZ LA SOURIS ET LE LAPIN | 14 | 38 |
| 303 | 7 | 23 | 397 1966 LANCET 1(7447):1136-& HELLMANN K IMMUNOSUPPRESSION BY THALIDOMIDE - IMPLICATIONS FOR TERATOLOGY | 14 | 20 |
| 304 | 3 | 9 | 423 1967 BIOCHEMICAL JOURNAL 104(2):570-& FABRO S; SMITH RL; WILLIAMS RT FATE OF HYDROLYSIS PRODUCTS OF THALIDOMIDE IN PREGNANT RABBIT | 14 | 17 |
| 305 | 5 | 12 | 560 1972 TERATOLOGY 5(2):233-& SCHUMACHER HJ; WILSON JG; TERAPANE J; JORDAN RR TERATOGENIC ACTIVITY OF A THALIDOMIDE ANALOG, EM12, IN RABBITS, RATS, AND MONKEYS | 14 | 32 |
| 306 | 3 | 36 | 668 1978 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 57(4):317-332 GOIHMANYAHR M; CONVIT J; RODRIGUEZOCHOA G; ARANZAZU N; VILLALBAPIMENTEL L; OCANTO A; ELENADEGOMEZ M SIGNIFICANCE OF NEUTROPHIL ACTIVATION IN REACTIONAL LEPROMATOUS LEPROSY - EFFECTS OF THALIDOMIDE INVIVO AND INVITRO - ACTIVATION IN ADJUVANT DISEASE | 14 | 23 |
| 307 | 4 | 8 | 985 1988 TRANSPLANTATION PROCEEDINGS 20(2):226-228 VOGELSANG GB; WELLS MC; SANTOS GW; CHEN TL; HESS AD COMBINATION LOW-DOSE THALIDOMIDE AND CYCLOSPORINE PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN A RAT MISMATCHED MODEL | 14 | 16 |
| 308 | 3 | 13 | 1020 1990 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 23(5):941-944 RUSTIN MHA; GILKES JJH; ROBINSON TWE PYODERMA-GANGRENOSUM ASSOCIATED WITH BEHCETS-DISEASE - TREATMENT WITH THALIDOMIDE | 14 | 27 |
| 309 | 9 | 25 | 1117 1994 ARCHIVES OF DERMATOLOGICAL RESEARCH 286(6):347-349 TSAMBAOS D; BOLSEN K; GEORGIOU S; MONASTIRLI A; GOERZ G EFFECTS OF ORAL THALIDOMIDE ON RAT-LIVER AND SKIN MICROSOMAL P450 ISOZYME ACTIVITIES AND ON URINARY PORPHYRIN EXCRETION - INTERACTION WITH ORAL HEXACHLOROBENZENE | 14 | 15 |
| 310 | 1 | 5 | 1166 1995 AIDS 9(6):658-659 SHARPSTONE D; ROWBOTTOM A; NELSON M; GAZZARD B THE TREATMENT OF MICROSPORIDIAL DIARRHEA WITH THALIDOMIDE | 14 | 34 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 311 | 2 | 3 | 1237 1996 ARCHIVES OF DERMATOLOGY 132(11):1392-1393 Dereure O; BassetSeguin N; Guilhou JJ Erosive lichen planus: Dramatic response to thalidomide | 14 | 24 |
| 312 | 8 | 17 | 1298 1996 TERATOLOGY 54(6):273-277 Castilla EE; AshtonProlla P; BarredaMejia E; Brunoni D; Cavalcanti DP; CorreaNeto J; Delgadillo JL; Dutra MG; Felix T; Giraldo A; Juarez N; LopezCamelo JS; Nazer J; Orioli IM; Paz JE; Pessoto MA; PinaNeto JM; Quadrelli R; Rittler M; Rueda S; Saltos M; Sanchez O; Schuler L Thalidomide, a current teratogen in South America | 14 | 17 |
| 313 | 26 | 80 | 1430 1998 CURRENT MEDICINAL CHEMISTRY 5(3):163-178 Hashimoto Y Novel biological response modifiers derived from thalidomide | 14 | 36 |
| 314 | 9 | 41 | 1446 1998 JOURNAL OF INFECTIOUS DISEASES 177(6):1563-1572 Tsenova L; Sokol K; Freedman VH; Kaplan G Combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death | 14 | 26 |
| 315 | 12 | 14 | 1453 1998 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 38(3):490-491 Hecker MS; Lebwohl MG Recalcitrant pyoderma gangrenosum: Treatment with thalidomide | 14 | 21 |
| 316 | 11 | 18 | 1455 1998 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 39(5):835-838 Lee JB; Koblenzer PS Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: A case report | 14 | 29 |
| 317 | 79 | 87 | 1478 1998 SEMINARS IN CUTANEOUS MEDICINE AND SURGERY 17(4):231-242 Stirling DI Thalidomide and its impact in dermatology | 14 | 17 |
| 318 | 6 | 12 | 1486 1999 ANNALS OF ONCOLOGY 10(7):857-859 Bruera E; Neumann CM; Pituskin E; Calder K; Ball G; Hanson J Thalidomide in patients with cachexia due to terminal cancer: Preliminary report | 14 | 30 |
| 319 | 11 | 15 | 1571 1999 JOURNAL OF RHEUMATOLOGY 26(11):2344-2347 Keesal N; Wasserman MJ; Bookman A; Lapp V; Weber DA; Keystone EC Thalidomide in the treatment of refractory rheumatoid arthritis | 14 | 17 |
| 320 | 3 | 14 | 1610 2000 AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 23(3):319-321 Patt YZ; Hassan MM; Lozano RD; Ellis LM; Peterson JA; Waugh KA Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide | 14 | 25 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 321 | 4 | 8 | 1677 2000 BLOOD 96(12):3995-3996 Koc S; Leisenring W; Flowers MED; Anasetti C; Deeg HJ; Nash RA; Sanders JE; Witherspoon RP; Appelbaum FR; Storb R; Martin PJ Thalidomide for treatment of patients with chronic graft-versus-host disease | 14 | 23 |
| 322 | 7 | 22 | 2253 2002 LEUKEMIA 16(1):1-6 Strupp C; Germing U; Aivado M; Misgeld E; Haas R; Gattermann N Thalidomide for the treatment of patients with myelodysplastic syndromes | 14 | 25 |
| 323 | 0 | 0 | 116 1962 LANCET 1(7223):271-& BURLEY DM THALIDOMIDE AND CONGENITAL ABNORMALITIES | 13 | 19 |
| 324 | 3 | 15 | 462 1968 ISRAEL JOURNAL OF MEDICAL SCIENCES 4(4):901-& SHESKIN J; SAGHER F; DORFMAN M; VONSCHRA.HW UNSATISFACTORY RESULTS WITH THALIDOMIDE AS A SPECIFIC TREATMENT FOR LEPROSY | 13 | 13 |
| 325 | 2 | 53 | 524 1971 FORTSCHRITTE DER NEUROLOGIE UND PSYCHIATRIE UND IHRER GRENZGEBIETE 39(1):15-& KRUCKE W; HARTROTT HH; SCHRODER JM; THOMAS E; GIBBELS E; SCHEID W LIGHT AND ELECTRON MICROSCOPIC STUDIES ON LATE STAGE OF THALIDOMIDE POLYNEUROPATHY | 13 | 18 |
| 326 | 6 | 25 | 774 1982 ARCHIVES OF DERMATOLOGICAL RESEARCH 274(3-4):363-367 MIYACHI Y; OZAKI M; UCHIDA K; NIWA Y EFFECTS OF THALIDOMIDE ON THE GENERATION OF OXYGEN INTERMEDIATES BY ZYMOSAN-STIMULATED NORMAL POLYMORPHONUCLEAR LEUKOCYTES | 13 | 21 |
| 327 | 14 | 36 | 826 1983 MEDICAL HYPOTHESES 10(4):437-443 HENDLER SS; MCCARTY MF THALIDOMIDE FOR AUTOIMMUNE-DISEASE | 13 | 14 |
| 328 | 2 | 2 | 879 1985 BRITISH JOURNAL OF DERMATOLOGY 112(5):632-632 KURKCUOGLU N; ATAKAN N; EKSIOGLU M THALIDOMIDE IN THE TREATMENT OF RECURRENT NECROTIC MUCOCUTANEOUS APHTHAE | 13 | 16 |
| 329 | 1 | 6 | 1052 1992 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 119(4):281-283 BENSAID P; MACHET L; VAILLANT L; MACHET MC; SCOTTO B; LORETTE G ADULT LANGERHANS-CELL HISTIOCYTOSIS - REGRESSION OF PAROTID-GLAND INVOLVEMENT AFTER THALIDOMIDE TREATMENT | 13 | 18 |
| 330 | 18 | 22 | 1138 1994 DERMATOLOGY 189(2):179-181 BIELSA I; TEIXIDO J; RIBERA M; FERRANDIZ C ERYTHRODERMA DUE TO THALIDOMIDE - REPORT OF 2 CASES | 13 | 17 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 331 | 3 | 6 | 1207 1995 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 33(5):837-838 BERGER TG; HOFFMAN C; THIEBERG MD PRURIGO NODULARIS AND PHOTOSENSITIVITY IN AIDS - TREATMENT WITH THALIDOMIDE | 13 | 22 |
| 332 | 7 | 14 | 1245 1996 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 226(2):439-444 Miyachi H; Azuma A; Hioki E; Iwasaki S; Kobayashi Y; Hashimoto Y Cell type-/inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production and its enantio-dependence | 13 | 20 |
| 333 | 9 | 27 | 1429 1998 CLINICAL PHARMACOLOGY & THERAPEUTICS 64(6):597-602 Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone | 13 | 15 |
| 334 | 25 | 30 | 1481 1999 AIDS RESEARCH AND HUMAN RETROVIRUSES 15(12):1047-1052 Noormohamed FH; Youle MS; Higgs CJ; Kook KA; Hawkins DA; Lant AF; Thomas SD Pharmacokinetics and hemodynamic effects of single oral doses of thalidomide in asymptomatic human immunodeficiency virus-infected subjects | 13 | 13 |
| 335 | 30 | 79 | 1487 1999 ANNALS OF THE RHEUMATIC DISEASES 58:107-113 Corral LG; Kaplan G Immunomodulation by thalidomide and thalidomide analogues | 13 | 18 |
| 336 | 17 | 32 | 1609 2000 AIDS RESEARCH AND HUMAN RETROVIRUSES 16(14):1345-1355 Kaplan G; Thomas S; Fierer DS; Mulligan K; Haslett PAJ; Fessel WJ; Smith LG; Kook KA; Stirling D; Schambelan M Thalidomide for the treatment of AIDS-associated wasting | 13 | 27 |
| 337 | 3 | 19 | 1878 2001 BLOOD 98(13):3846-3848 Moehler TM; Neben K; Benner A; Egerer G; Krasniqi F; Ho AD; Goldschmidt H Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy | 13 | 21 |
| 338 | 8 | 53 | 1894 2001 BRITISH JOURNAL OF HAEMATOLOGY 115(4):881-894 Zorat F; Shetty V; Dutt D; Lisak L; Nascimben F; Allampallam K; Dar S; York A; Gezer S; Venugopal P; Raza A The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes | 13 | 22 |
| 339 | 17 | 33 | 1938 2001 HAEMATOLOGICA 86(4):409-413 Tosi P; Ronconi S; Zamagni E; Cellini C; Grafone T; Cangini D; Pileri SA; Baccarani M; Tura S; Cavo M Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation | 13 | 21 |
| 340 | 7 | 29 | 1967 2001 JOURNAL OF NEURO-ONCOLOGY 54(1):31-38 Marx GM; Pavlakis N; McCowatt S; Boyle FM; Levi JA; Bell DR; Cook R; Biggs M; Little N; Wheeler HR Phase II study of Thalidomide in the treatment of recurrent glioblastoma multiforme | 13 | 20 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 341 | 12 | 35 | 2057 2002 BLOOD 99(12):4525-4530 Mitsiades N; Mitsiades CS; Poulaki V; Chauhan D; Richardson PG; Hideshima T; Munshi NC; Treon SP; Anderson KC Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications | 13 | 53 |
| 342 | 28 | 54 | 2161 2002 CLINICAL CANCER RESEARCH 8(6):1964-1973 Ando Y; Fuse E; Figg WD Thalidomide metabolism by the CYP2C subfamily | 13 | 14 |
| 343 | 23 | 42 | 2231 2002 JOURNAL OF IMMUNOLOGY 168(10):4914-4919 Dredge K; Marriott JB; Todryk SM; Muller GW; Chen R; Stirling DI; Dalgleish AG Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity | 13 | 28 |
| 344 | 11 | 24 | 279 1964 CANADIAN JOURNAL OF BIOCHEMISTRY AND PHYSIOLOGY 42(1):35-& BOYLEN JB; HORNE HH; JOHNSON WJ TERATOGENIC EFFECTS OF THALIDOMIDE + ITS METABOLITES ON DEVELOPING CHICK EMBRYO | 12 | 17 |
| 345 | 11 | 27 | 415 1967 AMERICAN JOURNAL OF VETERINARY RESEARCH 28(127):1823-& SZABO KT; STEELMAN RL EFFECTS OF MATERNAL THALIDOMIDE TREATMENT ON PREGNANCY FETAL DEVELOPMENT AND MORTALITY OF OFFSPRING IN RANDOM-BRED MICE | 12 | 12 |
| 346 | 5 | 8 | 427 1967 BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY 48(6):579-& VICKERS TH CONCERNING MORPHOGENESIS OF THALIDOMIDE DYSMELIA IN RABBITS | 12 | 18 |
| 347 | 9 | 66 | 465 1968 JOURNAL OF PHARMACEUTICAL SCIENCES 57(5):757-& SHEALY YF; OPLIGER CE; MONTGOME.JA SYNTHESIS OF D-AND L-THALIDOMIDE AND RELATED STUDIES | 12 | 29 |
| 348 | 3 | 17 | 799 1983 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 110(8):611-614 MOULIN G; BONNET F; BARRUT D; FRANC MP TREATMENT OF JESSNER-KANOF DISEASE WITH THALIDOMIDE | 12 | 21 |
| 349 | 1 | 2 | 830 1983 PRESSE MEDICALE 12(15):963-963 BARRIERE H SARCOIDOSIS OF THE SKIN - TREATMENT WITH THALIDOMIDE | 12 | 16 |
| 350 | 5 | 17 | 966 1988 CLINICAL AND EXPERIMENTAL DERMATOLOGY 13(6):408-410 MUNRO CS; COX NH PYODERMA GANGRENOSUM ASSOCIATED WITH BEHCETS SYNDROME - RESPONSE TO THALIDOMIDE | 12 | 19 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 351 | 3 | 6 | 972 1988 LANCET 1(8589):827-827 VOGELSANG GB; SANTOS GW; COLVIN OM; CHEN TL THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASE | 12 | 25 |
| 352 | 28 | 39 | 1006 1990 BIOMEDICINE & PHARMACOTHERAPY 44(4):199-204 HENEY D; BAILEY CC; LEWIS IJ THALIDOMIDE IN THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE | 12 | 14 |
| 353 | 2 | 34 | 1036 1991 BRITISH JOURNAL OF DERMATOLOGY 125(1):62-67 BURROWS NP; WALPORT MJ; HAMMOND AH; DAVEY N; JONES RR LUPUS-ERYTHEMATOSUS PROFUNDUS WITH PARTIAL C4-DEFICIENCY RESPONDING TO THALIDOMIDE | 12 | 23 |
| 354 | 3 | 5 | 1064 1992 LANCET 339(8789):365-365 WINTER W; FRANKUS E THALIDOMIDE ENANTIOMERS | 12 | 18 |
| 355 | 9 | 19 | 1171 1995 ARCHIVES OF DERMATOLOGY 131(9):1032-1035 GUILLAUME JC; MOULIN G; DIENG MT; POLI F; MOREL P; SOUTEYRAND P; BONNETBLANC JM; CLAUDY A; DANIEL F; VAILLANT L; BERNARD P; BOUILLIE MC; BOURNERIAS I; DENOEUX JP; LAMBERT D; LEONARD F; CHAUMEIL JC; REVUZ J CROSSOVER STUDY OF THALIDOMIDE VS PLACEBO IN JESSNERS LYMPHOCYTIC INFILTRATION OF THE SKIN | 12 | 17 |
| 356 | 2 | 14 | 1261 1996 EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 8(9):929-931 Postema PTE; denHaan P; vanHagen PM; vanBlankenstein M Treatment of colitis in Behcet's disease with thalidomide | 12 | 19 |
| 357 | 10 | 11 | 1306 1997 AMERICAN JOURNAL OF GASTROENTEROLOGY 92(1):169-170 Ball SC; Sepkowitz KA; Jacobs JL Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: Case report and review | 12 | 13 |
| 358 | 11 | 39 | 1338 1997 GASTROENTEROLOGY 112(6):1823-1829 Sharpstone D; Rowbottom A; Francis N; Tovey G; Ellis D; Barrett M; Gazzard B Thalidomide: A novel therapy for microsporidiosis | 12 | 42 |
| 359 | 16 | 59 | 1371 1997 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 396(1-2):45-64 Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J Thalidomide: lack of mutagenic activity across phyla and genetic endpoints | 12 | 14 |
| 360 | 4 | 5 | 1400 1998 ARCHIVES OF DERMATOLOGY 134(8):1045-1046 Rousseau L; Beylot-Barry M; Doutre MS; Beylot C Cutaneous sarcoidosis successfully treated with low doses of thalidomide | 12 | 25 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 361 | 7 | 13 | 1404 1998 ARTHRITIS AND RHEUMATISM 41(12):2273-2275 Ordi J; Cortes F; Martinez N; Mauri M; De Torres I; Vilardell M Thalidomide induces amenorrhea in patients with lupus disease | 12 | 19 |
| 362 | 2 | 4 | 1474 1998 PALLIATIVE MEDICINE 12(3):208-209 Deaner P Thalidomide for distressing night sweats in advanced malignant disease | 12 | 13 |
| 363 | 9 | 27 | 1530 1999 CLINICAL PHARMACOLOGY & THERAPEUTICS 65(5):483-490 Scheffler MR; Colburn W; Kook KA; Thomas SD Thalidomide does not alter estrogen-progesterone hormone single-dose pharmacokinetics | 12 | 12 |
| 364 | 20 | 40 | 1603 1999 SURGERY 125(5):536-544 Kotoh T; Dhar DK; Masunaga R; Tabara H; Tachibana M; Kubota H; Kohno H; Nagasue N Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice | 12 | 27 |
| 365 | 52 | 73 | 1822 2001 BIODRUGS 15(3):163-172 Singhal S; Mehta J Thalidomide in cancer - Potential uses and limitations | 12 | 16 |
| 366 | 12 | 22 | 1888 2001 BRITISH JOURNAL OF HAEMATOLOGY 114(1):78-83 Barosi G; Grossi A; Comotti B; Musto P; Gamba G; Marchetti M Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia | 12 | 23 |
| 367 | 5 | 5 | 2054 2002 BLOOD 99(11):4247-4248 Urbauer E; Kaufmann H; Nosslinger T; Raderer M; Drach J Thromboembolic events during treatment with thalidomide | 12 | 17 |
| 368 | 12 | 36 | 2136 2002 BRITISH JOURNAL OF HAEMATOLOGY 117(2):288-296 Elliott MA; Mesa RA; Li CY; Hook CC; Ansell SM; Levitt RM; Geyer SM; Tefferi A Thalidomide treatment in myelofibrosis with myeloid metaplasia | 12 | 21 |
| 369 | 37 | 67 | 2230 2002 JOURNAL OF IMMUNOLOGY 168(6):2644-2651 Majumdar S; Lamothe B; Aggarwal BB Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester | 12 | 24 |
| 370 | 19 | 50 | 2412 2003 BRITISH JOURNAL OF HAEMATOLOGY 120(1):18-26 Cavenagh JD; Oakervee H; UK Myeloma Forum; BSCH Haematology Oncology Task For Thalidomide in multiple myeloma: Current status and future prospects | 12 | 15 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 371 | 0 | 1 | 44 1961 JOURNAL OF PHARMACY AND PHARMACOLOGY 13:T117-& GREEN JN; BENSON BC SPECTROPHOTOMETRIC DETERMINATION OF THALIDOMIDE IN BODY FLUIDS | 11 | 12 |
| 372 | 0 | 0 | 123 1962 LANCET 1(7231):691-& FERGUSON AW THALIDOMIDE AND CONGENITAL ABNORMALITIES | 11 | 14 |
| 373 | 0 | 0 | 124 1962 LANCET 1(7231):691-& ROGERSON G THALIDOMIDE AND CONGENITAL ABNORMALITIES - REPLY | 11 | 13 |
| 374 | 4 | 4 | 272 1964 BIOCHEMICAL JOURNAL 90(1):P5-& FABRO S; SCHUMACHER H; STAGG BL; SMITH RL; WILLIAMS RT BIOLOGICAL ACTIVITY OF THALIDOMIDE METABOLITES | 11 | 15 |
| 375 | 6 | 12 | 293 1964 NATURE 201(492):1125-& FABRO S; SCHUMACHER H; SMITH RL; WILLIAMS RT IDENTIFICATION OF THALIDOMIDE IN RABBIT BLASTOCYSTS | 11 | 21 |
| 376 | 6 | 27 | 468 1968 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 161(2):348-& BAKAY B; NYHAN WL BINDING THALIDOMIDE BY MACROMOLECULES IN FETAL AND MATERNAL RAT | 11 | 16 |
| 377 | 2 | 13 | 604 1974 TERATOLOGY 10(3):283-291 MCBRIDE WG FETAL NERVE-CELL DEGENERATION PRODUCED BY THALIDOMIDE IN RABBITS | 11 | 28 |
| 378 | 14 | 24 | 658 1977 TERATOLOGY 16(1):79-82 MCBRIDE WG THALIDOMIDE EMBRYOPATHY | 11 | 29 |
| 379 | 0 | 0 | 741 1981 ARCHIVES OF DERMATOLOGICAL RESEARCH 270(2):229-229 KNOP J; HAPPLE R; VAKILZADEH F; MACHER E TREATMENT OF LUPUS-ERYTHEMATOSUS PROFUNDUS WITH THALIDOMIDE | 11 | 13 |
| 380 | 6 | 12 | 907 1985 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 5(3):149-158 BRAUN AG; WEINREB SL TERATOGEN METABOLISM - SPONTANEOUS DECAY PRODUCTS OF THALIDOMIDE AND THALIDOMIDE ANALOGS ARE NOT BIOACTIVATED BY LIVER-MICROSOMES | 11 | 15 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 381 | 4 | 10 | 1061 1992 JOURNAL OF INFECTIOUS DISEASES 166(4):939-940 GEORGHIOU PR; ALLWORTH AM THALIDOMIDE IN PAINFUL AIDS-ASSOCIATED PROCTITIS | 11 | 21 |
| 382 | 3 | 3 | 1094 1993 CLINICAL AND EXPERIMENTAL DERMATOLOGY 18(5):487-487 MISERY L; LARBRE B; LYONNET S; FAURE M; THIVOLET J REMISSION OF LANGERHANS CELL HISTIOCYTOSIS WITH THALIDOMIDE TREATMENT | 11 | 18 |
| 383 | 0 | 3 | 1129 1994 BRITISH MEDICAL JOURNAL 308(6944):1636-1636 READ AP THALIDOMIDE MAY BE A MUTAGEN - COMMENT | 11 | 13 |
| 384 | 5 | 19 | 1201 1995 JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS 674(2):287-292 Weinz C; Blaschke G Investigation of the in vitro biotransformation and simultaneous enantioselective separation of thalidomide and its neutral metabolites by capillary electrophoresis | 11 | 24 |
| 385 | 4 | 5 | 1238 1996 ARCHIVES OF DISEASE IN CHILDHOOD 74(1):64-65 Soler RA; Migliorati C; vanWaes H; Nadal D Thalidomide treatment of mucosal ulcerations in HIV infection | 11 | 14 |
| 386 | 6 | 35 | 1318 1997 BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 30(10):1199-1207 Moreira AL; Wang J; Sarno EN; Kaplan G Thalidomide protects mice against LPS-induced shock | 11 | 13 |
| 387 | 16 | 33 | 1450 1998 JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS 26(4):363-383 Hoglund P; Eriksson T; Bjorkman S A double-blind study of the sedative effects of the thalidomide enantiomers in humans | 11 | 15 |
| 388 | 13 | 66 | 1463 1998 MEDICAL HYPOTHESES 50(4):313-318 Argiles JM; Carbo N; Lopez-Soriano FJ Was tumour necrosis factor-alpha responsible for the fetal malformations associated with thalidomide in the early 1960s? | 11 | 12 |
| 389 | 9 | 19 | 1680 2000 BONE MARROW TRANSPLANTATION 26(8):865-869 Browne PV; Weisdorf DJ; DeFor T; Miller WJ; Davies SM; Filipovich A; McGlave PB; Ramsay NKC; Wagner J; Enright H Response to thalidomide therapy in refractory chronic graft-versus-host disease | 11 | 17 |
| 390 | 13 | 49 | 1696 2000 CLINICAL IMMUNOLOGY 97(2):109-120 Oliver SJ; Moreira A; Kaplan G Immune stimulation in scleroderma patients treated with thalidomide | 11 | 15 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 391 | 4 | 9 | 1721 2000 HAEMATOLOGICA 85(10):1111-1112 Pini M; Baraldi A; Pietrasanta D; Allione B; Depaoli L; Salvi F; Levis A Low-dose thalidomide in the treatment of refractory myeloma | 11 | 19 |
| 392 | 4 | 12 | 1775 2000 ONCOLOGY-NEW YORK 14(12):17-20 Eisen TG Thalidomide in solid tumors: The London experience | 11 | 15 |
| 393 | 2 | 12 | 1891 2001 BRITISH JOURNAL OF HAEMATOLOGY 115(2):313-315 Canepa L; Ballerini F; Varaldo R; Quintino S; Reni L; Clavio M; Miglino M; Pierri I; Gobbi M Thalidomide in agnogenic and secondary myelofibrosis | 11 | 16 |
| 394 | 53 | 140 | 1919 2001 DRUG SAFETY 24(2):87-117 Clark TE; Edom N; Larson J; Lindsey LJ Thalomid (R) (Thalidomide) capsules - A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing | 11 | 13 |
| 395 | 44 | 53 | 1925 2001 EXPERT OPINION ON BIOLOGICAL THERAPY 1(4):675-682 Marriott JB; Muller G; Stirling D; Dalgleish AG Immunotherapeutic and antitumour potential of thalidomide analogues | 11 | 15 |
| 396 | 18 | 29 | 1980 2001 MUSCLE & NERVE 24(8):1050-1057 Molloy FM; Floeter MK; Syed NA; Sandbrink F; Culcea E; Steinberg SM; Dahut W; Pluda J; Kruger EA; Reed E; Figg WD Thalidomide neuropathy in patients treated for metastatic prostate cancer | 11 | 16 |
| 397 | 6 | 18 | 2008 2001 SEMINARS IN ONCOLOGY 28(6):588-592 Blade J; Esteve J; Rosinol L; Perales M; Montoto S; Tuset M; Montserrat E Thalidomide in refractory and relapsing multiple myeloma | 11 | 13 |
| 398 | 8 | 8 | 2061 2002 BLOOD 100(6):2272-2273 Cavo M; Zamagni E; Cellini C; Tosi P; Cangini D; Cini M; Valdre L; Palareti G; Masini L; Tura S; Baccarani M Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy | 11 | 15 |
| 399 | 13 | 36 | 2194 2002 GUT 50(2):196-200 Bauditz J; Wedel S; Lochs H Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease | 11 | 25 |
| 400 | 4 | 12 | 2415 2003 BRITISH JOURNAL OF HAEMATOLOGY 121(5):768-771 Anagnostopoulos A; Weber D; Rankin K; Delasalle K; Alexanian R Thalidomide and dexamethasone for resistant multiple myeloma | 11 | 16 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 401 | 12 | 32 | 2516 2003 LEUKEMIA 17(4):775-779 Rajkumar SV; Gertz MA; Lacy MQ; Dispenzieri A; Fonseca R; Geyer SM; Iturria N; Kumar S; Lust JA; Kyle RA; Greipp PR; Witzig TE Thalidomide as initial therapy for early-stage myeloma | 11 | 18 |
| 402 | 0 | 0 | 15 1961 BRITISH MEDICAL JOURNAL 1(522):291-& KUENSSBERG EV; STANTON JB; SIMPSON JA IS THALIDOMIDE TO BLAME | 10 | 13 |
| 403 | 6 | 14 | 53 1962 ARCHIVES OF ENVIRONMENTAL HEALTH 5(2):100-& LENZ W; KNAPP K THALIDOMIDE EMBRYOPATHY | 10 | 62 |
| 404 | 8 | 13 | 437 1967 LANCET 1(7489):569-& DUKOR P; DIETRICH FM IMMUNOSUPRESSION BY THALIDOMIDE | 10 | 13 |
| 405 | 15 | 46 | 440 1967 MONATSHEFTE FUR CHEMIE 98(3):702-& KOCH H; KOTLAN J; BRAUN H THALIDOMIDE ANALOGUES .2. | 10 | 13 |
| 406 | 2 | 28 | 635 1977 ACTA NEUROPATHOLOGICA 39(3):271-280 SCHRODER JM; GIBBELS E UNMYELINATED NERVE-FIBERS IN SENILE NERVES AND IN LATE THALIDOMIDE NEUROPATHY - QUANTITATIVE ELECTRON-MICROSCOPIC STUDY | 10 | 33 |
| 407 | 13 | 27 | 915 1986 BRITISH JOURNAL OF DERMATOLOGY 115(3):367-370 RAMSELAAR CG; BOONE RM; KLUINNELEMANS HC THALIDOMIDE IN THE TREATMENT OF NEURO-BEHCETS SYNDROME | 10 | 20 |
| 408 | 15 | 59 | 958 1988 ARCHIVES OF TOXICOLOGY 61(3):165-179 MERKER HJ; HEGER W; SAMES K; STURJE H; NEUBERT D EMBRYOTOXIC EFFECTS OF THALIDOMIDE-DERIVATIVES IN THE NON-HUMAN PRIMATE CALLITHRIX-JACCHUS .1. EFFECTS OF 3-(1,3-DIHYDRO-1-OXO-2H-ISOINDOL-2-YL)-2,6-DIOXOPIPERIDINE (EM-12) ON SKELETAL DEVELOPMENT | 10 | 18 |
| 409 | 6 | 23 | 1212 1995 MICROBIAL PATHOGENESIS 19(4):245-255 BURROUGHS MH; TSENOVABERKOVA L; SOKOL K; OSSIG J; TUOMANEN E; KAPLAN G EFFECT OF THALIDOMIDE ON THE INFLAMMATORY RESPONSE IN CEREBROSPINAL-FLUID IN EXPERIMENTAL BACTERIAL-MENINGITIS | 10 | 19 |
| 410 | 12 | 22 | 1339 1997 IMMUNOPHARMACOLOGY 35(3):203-212 Shannon EJ; Morales MJ; Sandoval F Immunomodulatory assays to study structure-activity relationships of thalidomide | 10 | 13 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 411 | 0 | 0 | 1351 1997 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 278(14):1135-1137 Marwick C Thalidomide back - Under strict control | 10 | 13 |
| 412 | 8 | 26 | 1399 1998 ARCHIV DER PHARMAZIE 331(1):7-12 Teubert U; Zwingenberger K; Wnendt S; Eger K 5 '-substituted thalidomide analogs as modulators of TNF-alpha | 10 | 10 |
| 413 | 5 | 5 | 1461 1998 LANCET 352(9127):544-545 Stambe C; Wicks IP TNF alpha and response of treatment-resistant adult-onset Still's disease to thalidomide | 10 | 24 |
| 414 | 8 | 26 | 1498 1999 BIOLOGICAL & PHARMACEUTICAL BULLETIN 22(2):224-226 Shimazawa R; Miyachi H; Takayama H; Kuroda K; Kato F; Kato M; Hashimoto Y Antiangiogenic activity of tumor necrosis factor-alpha production regulators derived from thalidomide | 10 | 16 |
| 415 | 22 | 42 | 1522 1999 BRITISH JOURNAL OF CANCER 80(5-6):716-723 Cao Z; Joseph WR; Browne WL; Mountjoy KG; Palmer BD; Baguley BC; Ching LM Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid | 10 | 25 |
| 416 | 16 | 32 | 1548 1999 IMMUNOLOGY LETTERS 68(2-3):325-332 Rowland TL; McHugh SM; Deighton J; Ewan PW; Dearman RJ; Kimber I Selective down-regulation of T cell-and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone | 10 | 13 |
| 417 | 13 | 23 | 1569 1999 JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION 28(2):214-216 Weinstein TA; Sciubba JJ; Levine J Thalidomide for the treatment of oral aphthous ulcers in Crohn's disease | 10 | 21 |
| 418 | 10 | 22 | 1595 1999 PEDIATRICS 103(6):1295-1297 Shek LPC; Lee YS; Lee BW; Lehman TJA Thalidomide responsiveness in an infant with Behcet's syndrome | 10 | 16 |
| 419 | 11 | 22 | 1597 1999 PHARMACOTHERAPY 19(10):1177-1180 Horowitz SB; Stirling AL Thalidomide-induced toxic epidermal necrolysis | 10 | 10 |
| 420 | 4 | 4 | 1685 2000 BRITISH JOURNAL OF HAEMATOLOGY 110(3):754-754 Gutheil J; Finucane D Thalidomide therapy in refractory solid tumour patients | 10 | 13 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 421 | 8 | 33 | 1693 2000 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 119(1):123-129 La Maestra L; Zaninoni A; Marriott JB; Lazzarin A; Dalgleish AG; Barcellini W The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro | 10 | 18 |
| 422 | 16 | 22 | 1727 2000 INTERNATIONAL JOURNAL OF DERMATOLOGY 39(3):218-222 Kyriakis KP; Kontochristopoulos GJ; Panteleos DN Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus | 10 | 17 |
| 423 | 28 | 36 | 1750 2000 JOURNAL OF PHARMACY AND PHARMACOLOGY 52(7):807-817 Eriksson T; Bjorkman S; Roth B; Hoglund P Intravenous formulations of the enantiomers of thalidomide: Pharmacokinetic and initial pharmacodynamic characterization in man | 10 | 17 |
| 424 | 8 | 10 | 1941 2001 HAEMATOLOGICA 86(10):1108-1109 Camba L; Peccatori J; Pescarollo A; Tresoldi M; Corradini P; Bregni M Thalidomide and thrombosis in patients with multiple myeloma | 10 | 11 |
| 425 | 9 | 23 | 1966 2001 JOURNAL OF NEURO-ONCOLOGY 51(1):41-45 Short SC; Traish D; Dowe A; Hines F; Gore M; Brada M Thalidomide as an anti-angiogenic agent in relapsed gliomas | 10 | 20 |
| 426 | 11 | 18 | 1969 2001 JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION 32(2):178-181 Facchini S; Candusso M; Martelossi S; Liubich M; Panfili E; Ventura A Efficacy of long-term treatment with thalidomide in children and young adults with Crohn disease: Preliminary results | 10 | 17 |
| 427 | 8 | 18 | 2006 2001 SEMINARS IN ONCOLOGY 28(6):577-582 Barlogie B; Tricot G; Anaissie E Thalidomide in the management of multiple myeloma | 10 | 17 |
| 428 | 7 | 28 | 2030 2002 ANNALS OF ONCOLOGY 13(7):1029-1035 Escudier B; Lassau N; Couanet D; Angevin E; Mesrati F; Leborgne S; Garofano A; Leboulaire C; Dupouy N; Laplanche A Phase II trial of thalidomide in renal-cell carcinoma | 10 | 21 |
| 429 | 19 | 36 | 2053 2002 BLOOD 99(3):834-839 Steins MB; Padro T; Bieker R; Ruiz S; Kropff M; Kienast J; Kessler T; Buechner T; Berdel WE; Mesters RM Efficacy and safety of thalidomide in patients with acute myeloid leukemia | 10 | 24 |
| 430 | 6 | 26 | 2224 2002 JOURNAL OF CLINICAL ONCOLOGY 20(11):2610-2615 Hwu WJ; Krown SE; Panageas KS; Menell JH; Chapman PB; Livingston PO; Williams LJ; Quinn CJ; Houghton AN Temozolomide plus thalidomide in patients with advanced melanoma: Results of a dose-finding trial | 10 | 18 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 431 | 7 | 18 | 269 1964 ANATOMICAL RECORD 149(1):149-& DIPAOLO JA; PICKREN J; GATZEK H MALFORMATIONS INDUCED IN MOUSE BY THALIDOMIDE | 9 | 18 |
| 432 | 5 | 5 | 278 1964 BULLETIN OF THE JOHNS HOPKINS HOSPITAL 115(3):223-& DEKKER A; MEHRIZI A USE OF THALIDOMIDE AS TERATOGENIC AGENT IN RABBITS | 9 | 15 |
| 433 | 3 | 19 | 286 1964 JOURNAL OF REPRODUCTION AND FERTILITY 8(1):59-& HAY MF EFFECTS OF THALIDOMIDE ON PREGNANCY IN RABBIT | 9 | 30 |
| 434 | 8 | 13 | 334 1965 EXPERIENTIA 21(11):672-& SAWIN PB; CRARY D; FOX RR; WUEST HM THALIDOMIDE MALFORMATIONS AND GENETIC BACKGROUND IN RABBIT | 9 | 23 |
| 435 | 5 | 9 | 372 1966 CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL 8(6):299-& CAZORT RJ; SONG YK A TRIAL OF THALIDOMIDE IN PROGRESSIVE LEPRA REACTIONS | 9 | 11 |
| 436 | 15 | 31 | 449 1968 ARCHIVES OF ENVIRONMENTAL HEALTH 16(4):493-& WILLIAMS RT THALIDOMIDE - A STUDY OF BIOCHEMICAL TERATOLOGY | 9 | 20 |
| 437 | 5 | 24 | 550 1972 DEVELOPMENTAL BIOLOGY 28(1):61-& LASH JW; SAXEN L HUMAN TERATOGENESIS - IN-VITRO STUDIES ON THALIDOMIDE-INHIBITED CHONDROGENESIS | 9 | 26 |
| 438 | 8 | 17 | 568 1973 EXPERIENTIA 29(4):423-424 MEISE W; OCKENFEL.H; KOHLER F TERATOLOGICAL TESTING OF HYDROLYTIC PRODUCTS OF THALIDOMIDE | 9 | 15 |
| 439 | 9 | 21 | 590 1974 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 24(10):1616-1619 KOHLER F; KOCH H TERATOLOGY STUDY ON THALIDOMIDE-LIKE COMPOUNDS K-2004 AND K-2604 IN MOUSE AND RAT | 9 | 21 |
| 440 | 0 | 3 | 761 1981 PRACTITIONER 225(1355):721-& QUIBELL EP THE THALIDOMIDE EMBRYOPATHY - AN ANALYSIS FROM THE UK | 9 | 13 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 441 | 1 | 5 | 786 1982 NOUVELLE PRESSE MEDICALE 11(14):1080-1081 HAMZA M; CHAFFAI M; BENAYED H TREATMENT OF BEHCETS-DISEASE WITH THALIDOMIDE | 9 | 15 |
| 442 | 3 | 3 | 975 1988 LANCET 2(8623):1317-1317 HENEY D; LEWIS IJ; BAILEY CC THALIDOMIDE FOR CHRONIC GRAFT-VERSUS-HOST DISEASE IN CHILDREN | 9 | 14 |
| 443 | 19 | 39 | 998 1989 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 20(6):1060-1063 GRINSPAN D; BLANCO GF; AGUERO S TREATMENT OF APHTHAE WITH THALIDOMIDE | 9 | 23 |
| 444 | 6 | 13 | 1010 1990 DICP-THE ANNALS OF PHARMACOTHERAPY 24(11):1054-1056 NICOLAU DP; WEST TE THALIDOMIDE - TREATMENT OF SEVERE RECURRENT APHTHOUS STOMATITIS IN PATIENTS WITH AIDS | 9 | 17 |
| 445 | 1 | 4 | 1022 1990 LANCET 335(8705):1591-1591 YOULE M; HAWKINS D; GAZZARD B THALIDOMIDE IN HYPERALGIC PHARYNGEAL ULCERATION OF AIDS | 9 | 11 |
| 446 | 1 | 6 | 1046 1991 JOURNAL OF LIQUID CHROMATOGRAPHY 14(4):667-673 ABOULENEIN HY; ISLAM MR DIRECT HPLC SEPARATION OF THALIDOMIDE ENANTIOMERS USING CELLULOSE TRIS-4-METHYLPHENYL BENZOATE CHIRAL STATIONARY PHASE | 9 | 17 |
| 447 | 4 | 6 | 1055 1992 BRITISH JOURNAL OF DERMATOLOGY 126(1):92-93 MOISSON YF; JANIER M; CIVATTE J THALIDOMIDE FOR RECURRENT ERYTHEMA MULTIFORME | 9 | 12 |
| 448 | 8 | 18 | 1062 1992 JOURNAL OF MEDICAL GENETICS 29(10):716-723 SMITHELLS RW; NEWMAN CGH RECOGNITION OF THALIDOMIDE DEFECTS | 9 | 25 |
| 449 | 6 | 13 | 1063 1992 JOURNAL OF PHARMACEUTICAL SCIENCES 81(7):685-689 KRENN M; GAMCSIK MP; VOGELSANG GB; COLVIN OM; LEONG KW IMPROVEMENTS IN SOLUBILITY AND STABILITY OF THALIDOMIDE UPON COMPLEXATION WITH HYDROXYPROPYL-BETA-CYCLODEXTRIN | 9 | 16 |
| 450 | 5 | 7 | 1077 1992 TRANSPLANTATION PROCEEDINGS 24(6):2624-2625 OSTRAAT O; EKBERG H; SCHATZ H; RIESBECK K; ERIKSSON T THALIDOMIDE PROLONGS GRAFT-SURVIVAL IN RAT CARDIAC TRANSPLANTS | 9 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 451 | 4 | 4 | 1179 1995 BRITISH JOURNAL OF DERMATOLOGY 132(1):168-168 MEUNIER L; MARCK Y; RIBEYRE C; MEYNADIER J ADULT CUTANEOUS LANGERHANS CELL HISTIOCYTOSIS - REMISSION WITH THALIDOMIDE TREATMENT | 9 | 20 |
| 452 | 23 | 76 | 1280 1996 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 277(3):1649-1658 Arlen RR; Wells PG Inhibition of thalidomide teratogenicity by acetylsalicylic acid: Evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate | 9 | 15 |
| 453 | 7 | 20 | 1305 1997 AIDS RESEARCH AND HUMAN RETROVIRUSES 13(18):1625-1631 Marriott JB; Cookson S; Carlin E; Youle M; Hawkins DA; Nelson M; Pearson P; Vaughan AN; Gazzard B; Dalgleish AG A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: Clinical tolerance and effect on activation markers and cytokines | 9 | 14 |
| 454 | 2 | 8 | 1333 1997 DERMATOLOGY 195(4):359-361 Ferrandiz C; Carrascosa JM; Just M; Bielsa I; Ribera M Sequential combined therapy with thalidomide and narrow-band (TLO1) UVB in the treatment of prurigo nodularis | 9 | 11 |
| 455 | 5 | 9 | 1372 1997 NATURE 385(6614):303-304 Wnendt S; Zwingenberger K Thalidomide's chirality | 9 | 16 |
| 456 | 3 | 25 | 1440 1998 INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY 116(1):60-66 Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment | 9 | 12 |
| 457 | 0 | 0 | 1443 1998 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 280(10):872-872 Nightingale SL Thalidomide approved for erythema nodosum leprosum | 9 | 11 |
| 458 | 3 | 9 | 1467 1998 NATURE 396(6709):322-323 Tabin CJ A developmental model for thalidomide defects | 9 | 20 |
| 459 | 8 | 11 | 1475 1998 REVUE DE MEDECINE INTERNE 19(3):196-198 Lair G; Marie I; Cailleux N; Blot E; Boullie MC; Courville P; Lauret P; Levesque H; Courtois H Langerhans cell histiocytosis in adult patients: cutaneous and mucous localizations improving with thalidomide | 9 | 13 |
| 460 | 10 | 31 | 1526 1999 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 118(2):315-321 Oliver SJ; Freeman SL; Corral LG; Ocampo CJ; Kaplan G Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis | 9 | 13 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 461 | 0 | 0 | 1576 1999 LANCET 354(9182):925-925 Larkin M Low-dose thalidomide seems to be effective in multiple myeloma | 9 | 14 |
| 462 | 14 | 57 | 1774 2000 ONCOLOGY-NEW YORK 14(12):11-16 Rajkumar SV Thalidomide in multiple myeloma | 9 | 17 |
| 463 | 8 | 35 | 1788 2000 SEMINARS IN HEMATOLOGY 37(1):26-34 Thomas DA Pilot studies of thalidomide in acute myelogenous leukemia, myelodysplastic syndromes, and myeloproliferative disorders | 9 | 13 |
| 464 | 65 | 116 | 1808 2001 ANNALS OF MEDICINE 33(8):516-525 Ginsburg PM; Dassopoulos T; Ehrenpreis ED Thalidomide treatment for refractory Crohn's disease: a review. of the history, pharmacological mechanisms and clinical literature | 9 | 13 |
| 465 | 34 | 70 | 1990 2001 ONCOLOGY-NEW YORK 15(7):867-874 Rajkumar SV Current status of thalidomide in the treatment of cancer | 9 | 14 |
| 466 | 8 | 30 | 2051 2002 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 12(7):1043-1046 Noguchi T; Shimazawa R; Nagasawa K; Hashimoto Y Thalidomide and its analogues as cyclooxygenase inhibitors | 9 | 11 |
| 467 | 4 | 20 | 2060 2002 BLOOD 100(6):2263-2265 Neben K; Mytilineos J; Moehler TM; Preiss A; Kraemer A; Ho AD; Opelz G; Goldschmidt H Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma | 9 | 19 |
| 468 | 10 | 36 | 2134 2002 BRITISH JOURNAL OF CANCER 87(10):1166-1172 Dredge K; Marriott JB; Macdonald CD; Man HW; Chen R; Muller GW; Stirling D; Dalgleish AG Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects | 9 | 15 |
| 469 | 17 | 24 | 2164 2002 CLINICAL CANCER RESEARCH 8(11):3377-3382 Neben K; Moehler T; Benner A; Kraemer A; Egerer G; Ho AD; Goldschmidt H Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma | 9 | 13 |
| 470 | 20 | 24 | 2235 2002 JOURNAL OF INVESTIGATIVE DERMATOLOGY 119(5):1020-1026 Bastuji-Garin S; Ochonisky S; Bouche P; Gherardi RK; Duguet C; Djerradine Z; Poli F; Revuz J; Thalidomide Neuropathy Study Grp Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients | 9 | 12 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 471 | 27 | 34 | 2290 2002 THERAPEUTIC DRUG MONITORING 24(1):104-110 Price DK; Ando Y; Kruger EA; Weiss M; Figg WD 5 '-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis | 9 | 10 |
| 472 | 23 | 39 | 2532 2003 MAYO CLINIC PROCEEDINGS 78(1):34-39 Kumar S; Gertz MA; Dispenzieri A; Lacy MQ; Geyer SM; Iturria NL; Fonseca R; Hayman SR; Lust JA; Kyle RA; Greipp PR; Witzig TE; Rajkumar SV Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma | 9 | 20 |
| 473 | 4 | 24 | 43 1961 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 134(1):60-& KUHN WL; VANMAANEN EF CENTRAL NERVOUS SYSTEM EFFECTS OF THALIDOMIDE | 8 | 85 |
| 474 | 3 | 7 | 88 1962 CANADIAN MEDICAL ASSOCIATION JOURNAL 86(16):744-& RODIN AE; KOLLER LA; TAYLOR JD ASSOCIATION OF THALIDOMIDE (KEVADON) WITH CONGENITAL ANOMALIES | 8 | 13 |
| 475 | 1 | 1 | 113 1962 LANCET 1(7220):100-& BURLEY DM THALIDOMIDE AND CONGENITAL ABNORMALITIES | 8 | 10 |
| 476 | 4 | 10 | 166 1962 NEW ENGLAND JOURNAL OF MEDICINE 266(24):1268-& COHEN S THALIDOMIDE POLYNEUROPATHY | 8 | 10 |
| 477 | 2 | 3 | 213 1963 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES 256(12):2719-& SALZGEBER B; SALAUN J TERATOGENESE EXPERIMENTALE - MALFORMATIONS DE MEMBRES OBTENUES CHEZ LEMBRYON DE POULET APRES TRAITEMENT PAR LA THALIDOMIDE | 8 | 14 |
| 478 | 4 | 8 | 249 1963 NATURE 200(491):1016-& ROE FJC; MITCHLEY BC THALIDOMIDE AND NEOPLASIA | 8 | 13 |
| 479 | 4 | 17 | 258 1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 114(2):326-& FRANK O; HUTNER SH; SOBOTKA H; BAKER H TOXICITY TO PROTOZOA OF THALIDOMIDE BREAKDOWN PRODUCTS - COUNTERACTION BY NICOTINIC ACID AND GLUTAMINE | 8 | 12 |
| 480 | 0 | 0 | 259 1963 SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION 15(1):102-& NYSTROM C BIOCHEMICAL EFFECTS OF THALIDOMIDE - A PRELIMINARY REPORT | 8 | 12 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 481 | 0 | 2 | 275 1964 BRITISH MEDICAL JOURNAL 1(539):1090-& LUTWAKMANN C OBSERVATIONS ON PROGENY OF THALIDOMIDE-TREATED MALE RABBITS | 8 | 36 |
| 482 | 3 | 10 | 304 1965 ACTA CHEMICA SCANDINAVICA 19(5):1266-& FURBERG S STRUCTURAL RELATIONSHIP BETWEEN THALIDOMIDE AND NUCLEOSIDES | 8 | 13 |
| 483 | 7 | 23 | 311 1965 ANNALES PAEDIATRICI 205(5):341-& KAJII T THALIDOMIDE EXPERIENCE IN JAPAN | 8 | 8 |
| 484 | 0 | 12 | 363 1966 BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY 47(2):186-& PEARN JH; VICKERS TH RABBIT THALIDOMIDE EMBRYOPATHY | 8 | 12 |
| 485 | 6 | 14 | 387 1966 JOURNAL OF REPRODUCTION AND FERTILITY 11(1):157-& FRITZ H FAILURE OF THALIDOMIDE METABOLITES TO PRODUCE MALFORMATIONS IN RABBIT EMBRYO | 8 | 11 |
| 486 | 2 | 7 | 425 1967 BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY 48(1):107-& VICKERS TH THALIDOMIDE EMBRYOPATHY IN HYBRID RABBITS | 8 | 20 |
| 487 | 5 | 8 | 473 1968 TRANSPLANTATION 6(3):476-& MOUZAS GL; GERSHON RK EFFECT OF THALIDOMIDE ON SKIN ALLOGRAFTS IN MICE - SURVIVAL OF GRAFTS | 8 | 9 |
| 488 | 13 | 34 | 527 1971 MONATSHEFTE FUR CHEMIE 102(2):609-& KOCH H; KOTLAN J; FARKOUH E; LINDNER M THALIDOMIDE ANALOGUES .3. | 8 | 14 |
| 489 | 2 | 2 | 573 1973 LANCET 2(7824):324-325 LEVY L; FASAL P; LEVAN NE; FREEDMAN RI TREATMENT OF ERYTHEMA-NODOSUM LEPROSUM WITH THALIDOMIDE | 8 | 10 |
| 490 | 3 | 12 | 576 1973 LANCET 2(7837):1058-1061 MCCREDIE J THALIDOMIDE AND CONGENITAL CHARCOTS JOINTS | 8 | 49 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 491 | 4 | 7 | 585 1973 TERATOLOGY 8(2):163-166 KAJII T; KIDA M; TAKAHASH.K EFFECT OF THALIDOMIDE INTAKE DURING 113 HUMAN PREGNANCIES | 8 | 21 |
| 492 | 0 | 0 | 628 1976 PHARMACOLOGIST 18(2):218-218 HASTINGS RC; MORALES MJ; SHANNON EJ STUDIES ON MECHANISM OF ACTION OF THALIDOMIDE IN LEPROSY | 8 | 11 |
| 493 | 3 | 17 | 850 1984 DERMATOLOGICA 168(4):182-188 GENVO MF; FAURE M; THIVOLET J THALIDOMIDE AND THALIDOMIDE WITH COLCHICINE IN THE TREATMENT OF APHTHOSIS, RECURRENT MUCOCUTANEOUS APHTHAE AND BEHCETS-DISEASE | 8 | 16 |
| 494 | 13 | 38 | 909 1985 TERATOLOGY 32(1):133-144 NEWMAN CGH TERATOGEN UPDATE - CLINICAL ASPECTS OF THALIDOMIDE EMBRYOPATHY - A CONTINUING PREOCCUPATION | 8 | 27 |
| 495 | 5 | 17 | 937 1986 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 41(11-12):1057-1061 KOCH HP; CZEJKA MJ EVIDENCE FOR THE INTERCALATION OF THALIDOMIDE INTO DNA - CLUE TO THE MOLECULAR MECHANISM OF THALIDOMIDE TERATOGENICITY | 8 | 10 |
| 496 | 3 | 46 | 959 1988 ARCHIVES OF TOXICOLOGY 61(3):180-191 NEUBERT D; HEGER W; MERKER HJ; SAMES K; MEISTER R EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES IN THE NON-HUMAN PRIMATE CALLITHRIX-JACCHUS .2. ELUCIDATION OF THE SUSCEPTIBLE PERIOD AND OF THE VARIABILITY OF EMBRYONIC STAGES | 8 | 21 |
| 497 | 3 | 11 | 960 1988 ARCHIVES OF TOXICOLOGY 62(2-3):200-204 SCHMAHL HJ; NAU H; NEUBERT D THE ENANTIOMERS OF THE TERATOGENIC THALIDOMIDE ANALOG EM-12 .1. CHIRAL INVERSION AND PLASMA PHARMACOKINETICS IN THE MARMOSET MONKEY | 8 | 18 |
| 498 | 2 | 3 | 973 1988 LANCET 2(8610):568-568 RINGDEN O; ASCHAN J; WESTERBERG L THALIDOMIDE FOR SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE | 8 | 9 |
| 499 | 1 | 7 | 1007 1990 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 8(4):427-427 HAMZA M BEHCETS-DISEASE, PALMOPLANTAR PUSTULOSIS AND HLA-B27 TREATMENT WITH THALIDOMIDE | 8 | 9 |
| 500 | 3 | 4 | 1057 1992 GENITOURINARY MEDICINE 68(6):424-425 STRAZZI S; LEBBE C; GEOFFRAY C; ABLON G; MOREL P; VEROLA O; MOLINA JM APHTHOUS ULCERS IN HIV-INFECTED PATIENTS - TREATMENT WITH THALIDOMIDE | 8 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 501 | 1 | 6 | 1059 1992 INTERNATIONAL JOURNAL OF DERMATOLOGY 31(8):599-600 BERNAL JE; DURAN MM; LONDONO F; UMANA A CELLULAR IMMUNE EFFECTS OF THALIDOMIDE IN ACTINIC PRURIGO | 8 | 13 |
| 502 | 32 | 85 | 1115 1994 ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS 13(4):177-192 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 8 | 11 |
| 503 | 2 | 2 | 1131 1994 BRITISH MEDICAL JOURNAL 309(6952):477-477 SMITHELLS RW THALIDOMIDE MAY BE A MUTAGEN | 8 | 9 |
| 504 | 5 | 12 | 1148 1994 LANCET 343(8895):432-433 JAKEMAN P; SMITH WCS THALIDOMIDE IN LEPROSY REACTION | 8 | 14 |
| 505 | 7 | 18 | 1222 1995 TETRAHEDRON-ASYMMETRY 6(6):1249-1252 ROBIN S; ZHU J; GALONS H; PHAMHUY C; CLAUDE JR; TOMAS A; VIOSSAT B A CONVENIENT ASYMMETRIC-SYNTHESIS OF THALIDOMIDE | 8 | 19 |
| 506 | 10 | 13 | 1249 1996 BONE MARROW TRANSPLANTATION 17(2):291-293 Forsyth CJ; Cremer PD; Torzillo P; Iland HJ; Young GAR Thalidomide responsive chronic pulmonary GVHD | 8 | 14 |
| 507 | 4 | 17 | 1251 1996 CANCER LETTERS 101(1):21-24 Pollard M Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats | 8 | 12 |
| 508 | 10 | 20 | 1281 1996 JOURNAL OF SURGICAL RESEARCH 63(1):143-146 Schmidt H; Rush B; Simonian G; Murphy T; Hsieh J; Condon M Thalidomide inhibits TNF response and increases survival following endotoxin injection in rats | 8 | 17 |
| 509 | 10 | 12 | 1310 1997 ANALYTICA CHIMICA ACTA 339(1-2):91-97 Simmons BR; Lush RM; Figg WD A reversed-phase high performance liquid chromatography method using solid phase extraction to quantitate thalidomide in human serum | 8 | 10 |
| 510 | 7 | 20 | 1408 1998 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 8(9):1071-1076 Niwayama S; Loh C; Turk BE; Liu JO; Miyachi H; Hashimoto Y Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-alpha production is associated with a change of mechanism of action | 8 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 511 | 24 | 35 | 1523 1999 CANCER CHEMOTHERAPY AND PHARMACOLOGY 43:S78-S84 Dixon SC; Kruger EA; Bauer KS; Figg WD Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells | 8 | 14 |
| 512 | 23 | 32 | 1545 1999 GASTROENTEROLOGY 117(6):1485-1488 Sands BE; Podolsky DK New life in a sleeper: Thalidomide and Crohn's disease | 8 | 25 |
| 513 | 5 | 17 | 1550 1999 IMMUNOPHARMACOLOGY 43(1):59-64 Dunzendorfer S; Herold M; Wiedermann CJ Inducer-specific bidirectional regulation of endothelial interleukin-8 production by thalidomide | 8 | 8 |
| 514 | 10 | 18 | 1560 1999 JOURNAL OF CHROMATOGRAPHY B 723(1-2):255-264 Meyring M; Strickmann D; Chankvetadze B; Blaschke G; Desiderio C; Fanali S Investigation of the in vitro biotransformation of R-(+)- thalidomide by HPLC, nano-HPLC, CEC and HPLC-APCI-MS | 8 | 20 |
| 515 | 9 | 9 | 1561 1999 JOURNAL OF CHROMATOGRAPHY B 734(2):203-210 Torano JS; Verbon A; Guchelaar HJ Quantitative determination of thalidomide in human serum with high-performance liquid chromatography using protein precipitation with trichloroacetic acid and ultraviolet detection | 8 | 8 |
| 516 | 5 | 11 | 1602 1999 SLEEP 22(1):113-115 Kanbayashi T; Shimizu T; Takahashi Y; Kitajima T; Takahashi K; Saito Y; Hishikawa Y Thalidomide increases both REM and stage 3-4 sleep in human adults: A preliminary study | 8 | 10 |
| 517 | 13 | 20 | 1724 2000 IMMUNOPHARMACOLOGY 46(2):175-179 Shannon E; Aseffa A; Pankey G; Sandoval F; Lutz B Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+cells in their blood | 8 | 8 |
| 518 | 4 | 17 | 1736 2000 JOURNAL OF CHILD NEUROLOGY 15(8):497-503 Schoeman JF; Springer P; Ravenscroft A; Donald PR; Bekker LG; van Rensburg AJ; Hanekom WA; Haslett PAJ; Kaplan G Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role | 8 | 10 |
| 519 | 8 | 15 | 1748 2000 JOURNAL OF INFECTIOUS DISEASES 182(3):983-987 Lokensgard JR; Hu SX; van Fenema EM; Sheng WS; Peterson PK Effect of thalidomide on chemokine production by human microglia | 8 | 11 |
| 520 | 4 | 7 | 1801 2001 AMERICAN JOURNAL OF GASTROENTEROLOGY 96(4):1305-1306 Ginsburg PM; Hanan I; Ehrenpreis ED Treatment of severe esophageal Crohn's disease with thalidomide | 8 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 521 | 4 | 18 | 1824 2001 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 7(5):265-273 Arora M; Wagner JE; Davies SM; Blazar BR; Defor T; Enright H; Miller WF; Weisdorf DJ Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease | 8 | 15 |
| 522 | 8 | 17 | 1976 2001 LEUKEMIA & LYMPHOMA 42(4):683-+ Avigdor A; Raanani P; Levi I; Hardan I; Ben-Bassat I Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma | 8 | 9 |
| 523 | 6 | 16 | 2025 2002 AMERICAN JOURNAL OF MEDICINE 112(5):412-413 Badros AZ; Siegel E; Bodenner D; Zangari M; Zeldis J; Barlogie B; Tricot G Hypothyroidism in patients with multiple myeloma following treatment with thalidomide | 8 | 9 |
| 524 | 6 | 43 | 2148 2002 CANCER 95(8):1629-1636 Desai AA; Vogelzang NJ; Rini BI; Ansari R; Krauss S; Stadler WM A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma | 8 | 14 |
| 525 | 14 | 25 | 2228 2002 JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 17(2):135-139 Bariol C; Meagher AP; Vickers CR; Byrnes DJ; Edwards PD; Hing M; Wettstein AR; Field A Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease | 8 | 13 |
| 526 | 0 | 0 | 119 1962 LANCET 1(7224):326-& KOHLER HG; FISHER AM; DUNN PM THALIDOMIDE AND CONGENITAL ABNORMALITIES | 7 | 17 |
| 527 | 0 | 0 | 122 1962 LANCET 1(7229):591-& SMITHELLS RW THALIDOMIDE AND CONGENITAL ABNORMALITIES | 7 | 9 |
| 528 | 2 | 4 | 179 1962 SCIENTIFIC AMERICAN 207(2):29-& TAUSSIG HB THALIDOMIDE SYNDROME | 7 | 15 |
| 529 | 0 | 0 | 235 1963 LANCET 1(728):772-& EHMANN B TERATOGENIC EFFECTS OF THALIDOMIDE | 7 | 13 |
| 530 | 1 | 2 | 248 1963 NATURE 199(489):1204-& DEBOCK CA; PETERS A EFFECT OF THALIDOMIDE ON DEVELOPMENT OF CHICK EMBRYO | 7 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 531 | 10 | 22 | 323 1965 CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 43(1):69-& MCCOLL JD; GLOBUS M; ROBINSON S AN ATTEMPTED REVERSAL OF THALIDOMIDE EMBRYOPATHY IN RAT BY GLUTAMINE | 7 | 10 |
| 532 | 5 | 19 | 342 1965 LANCET 2(7421):1059-& [Anon] ANOTHER CHANCE FOR THALIDOMIDE | 7 | 0 |
| 533 | 7 | 39 | 384 1966 JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY 16:289-& JURAND A EARLY CHANGES IN LIMB BUDS OF CHICK EMBRYOS AFTER THALIDOMIDE TREATMENT | 7 | 33 |
| 534 | 8 | 13 | 386 1966 JOURNAL OF PHARMACY AND PHARMACOLOGY 18(1):46-& NICHOLLS PJ A NOTE ON ABSORPTION AND EXCRETION OF 14C-LABELLED THALIDOMIDE IN PREGNANT MICE | 7 | 7 |
| 535 | 3 | 4 | 409 1966 SCIENCE 154(3754):1362-& SCHUMACHER H; BLAKE D; GILLETTE J; WUEST HM; FOX RR THALIDOMIDE SOLUTIONS | 7 | 7 |
| 536 | 3 | 10 | 459 1968 EXPERIENTIA 24(10):993-& WUEST HM; FOX RR; CRARY DD RELATIONSHIP BETWEEN TERATOGENY AND STRUCTURE IN THALIDOMIDE FIELD | 7 | 14 |
| 537 | 2 | 7 | 528 1971 NATURE 232(5313):634-& LASH JW; SAXEN L EFFECT OF THALIDOMIDE ON HUMAN EMBRYONIC TISSUES | 7 | 18 |
| 538 | 0 | 0 | 593 1974 INTERNATIONAL JOURNAL OF DERMATOLOGY 13(1):20-25 KLUKEN N; WENTE W INDICATIONS FOR THALIDOMIDE THERAPY FOR LEPROSY | 7 | 9 |
| 539 | 11 | 28 | 620 1976 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 18(2):189-197 STEPHENSON JBP EPILEPSY - NEUROLOGICAL COMPLICATION OF THALIDOMIDE EMBRYOPATHY | 7 | 11 |
| 540 | 5 | 17 | 647 1977 EXPERIENTIA 33(10):1384-1386 PETTER C EARLY FETAL THROMBOSIS INDUCED BY THALIDOMIDE IN MOUSE - POSSIBLE EXPLANATION FOR TERATOGENICITY | 7 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 541 | 2 | 6 | 721 1980 CANADIAN JOURNAL OF PHARMACEUTICAL SCIENCES 15(2):21-23 JACKSON AJ; SCHUMACHER HJ IDENTIFICATION OF URINARY METABOLITES OF EM12 N-(2',6'- DIOXOPIPERIDEN-3'-YL)-PHTHALIMIDINE, A TERATOGENIC ANALOG OF THALIDOMIDE IN RATS AND RABBITS | 7 | 7 |
| 542 | 2 | 11 | 722 1980 CHEMISCHE BERICHTE-RECUEIL 113(6):2318-2322 BLASCHKE G; KRAFT HP; MARKGRAF H CHROMATOGRAPHIC RESOLUTIONS OF RACEMATES .10. OPTICAL RESOLUTION OF THALIDOMIDE AND OTHER GLUTARIMIDE DERIVATIVES | 7 | 31 |
| 543 | 0 | 13 | 737 1980 TERATOLOGY 22(2):179-182 HENDRICKX AG; HELM FC NON-TERATOGENICITY OF A STRUCTURAL ANALOG OF THALIDOMIDE IN PREGNANT BABOONS (PAPIO-CYNOCEPHALUS) | 7 | 15 |
| 544 | 0 | 7 | 738 1980 TERATOLOGY 22(2):183-185 SCOTT WJ; WILSON JG; HELM FC A METABOLITE OF A STRUCTURAL ANALOG OF THALIDOMIDE LACKS TERATOGENIC EFFECT IN PREGNANT RHESUS-MONKEYS | 7 | 9 |
| 545 | 20 | 39 | 780 1982 DERMATOLOGICA 165(4):355-362 SCOLARI F; HARMS M; GILARDI S THALIDOMIDE IN THE TREATMENT OF CHRONIC LUPUS-ERYTHEMATOSUS | 7 | 9 |
| 546 | 30 | 66 | 821 1983 HAUTARZT 34(2):66-72 HUNZIKER T; KREBS A THALIDOMIDE IN DERMATOLOGY | 7 | 7 |
| 547 | 9 | 13 | 880 1985 BRITISH JOURNAL OF DERMATOLOGY 113:141-144 POWELL RJ; ALLEN BR; JENKINS JS; STEELE L; HUNNEYBALL I; MAURICE PDL; LITTLEWOOD SM INVESTIGATION AND TREATMENT OF OROGENITAL ULCERATION - STUDIES ON A POSSIBLE MODE OF ACTION OF THALIDOMIDE | 7 | 9 |
| 548 | 15 | 15 | 899 1985 LANCET 2(8446):80-81 [Anon] THALIDOMIDE IN DERMATOLOGY AND LEPROSY | 7 | 0 |
| 549 | 10 | 11 | 948 1987 ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 64(3):289-292 EISENBUD L; HOROWITZ I; KAY B RECURRENT APHTHOUS STOMATITIS OF THE BEHCETS TYPE - SUCCESSFUL TREATMENT WITH THALIDOMIDE | 7 | 18 |
| 550 | 11 | 33 | 995 1989 JOURNAL OF AUTOIMMUNITY 2(2):197-202 CRAIN E; MCINTOSH KR; GORDON G; PESTRONK A; DRACHMAN DB THE EFFECT OF THALIDOMIDE ON EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS | 7 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 551 | 10 | 15 | 996 1989 JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS 488(2):417-425 WINCKLER K; KLINKMULLER KD; SCHMAHL HJ DETERMINATION OF THE THALIDOMIDE ANALOGS 2-(2,6-DIOXOPIPERIDINE-3-YL)PHTHALIMIDINE (EM 12), 2-(2,6-DIOXOPIPERIDINE-4-YL)PHTHALIMIDINE (EM 16) AND THEIR METABOLITES IN BIOLOGICAL SAMPLES | 7 | 7 |
| 552 | 7 | 15 | 1001 1989 TOXICOLOGY LETTERS 45(1):23-33 SCHMAHL HJ; HEGER W; NAU H THE ENANTIOMERS OF THE TERATOGENIC THALIDOMIDE ANALOG EM-12 .2. CHEMICAL-STABILITY, STEREOSELECTIVITY OF METABOLISM AND RENAL EXCRETION IN THE MARMOSET MONKEY | 7 | 17 |
| 553 | 0 | 6 | 1014 1990 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 263(11):1467-1468 RANDALL T THALIDOMIDE BACK IN THE NEWS, BUT IN MORE FAVORABLE CIRCUMSTANCES | 7 | 21 |
| 554 | 0 | 1 | 1016 1990 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 263(11):1474-1474 RANDALL T INVESTIGATIONAL NEW DRUG (US) ORPHAN TRIALS NOW USE THALIDOMIDE FROM 2 SOURCES | 7 | 11 |
| 555 | 0 | 1 | 1066 1992 LANCET 339(8800):1057-1057 HAWKINS DF THALIDOMIDE FOR SYSTEMIC LUPUS-ERYTHEMATOSUS | 7 | 8 |
| 556 | 33 | 38 | 1090 1993 BONE MARROW TRANSPLANTATION 12:S26-S28 EHNINGER G; EGER K; STUHLER A; SCHULER U THALIDOMIDE - THE NEED FOR A NEW CLINICAL-EVALUATION OF AN OLD DRUG | 7 | 8 |
| 557 | 7 | 20 | 1164 1994 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 14(3):115-122 HEGER W; SCHMAHL HJ; KLUG S; FELIES A; NAU H; MERKER HJ; NEUBERT D EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES IN THE NONHUMAN PRIMATE CALLITHRIX-JACCHUS .4. TERATOGENICITY OF MU-G/KG DOSES OF THE EM12 ENANTIOMERS | 7 | 15 |
| 558 | 7 | 23 | 1174 1995 BIOLOGICAL & PHARMACEUTICAL BULLETIN 18(9):1228-1233 SASAKI K; SHIBATA Y; HASHIMOTO Y; IWASAKI S BENZYLPHTHALIMIDES AND PHENETHYLPHTHALIMIDES WITH THALIDOMIDE-LIKE ACTIVITY ON THE PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA | 7 | 18 |
| 559 | 5 | 10 | 1187 1995 DIGESTIVE DISEASES AND SCIENCES 40(5):1147-1148 NAUM SM; MOLLOY PJ; KANIA RJ; MCGARR J; VANTHIEL DH USE OF THALIDOMIDE IN TREATMENT AND MAINTENANCE OF IDIOPATHIC ESOPHAGEAL ULCERS IN HIV+ INDIVIDUALS | 7 | 11 |
| 560 | 4 | 11 | 1216 1995 NATURE 375(6531):453-453 ASHBY J; TINWELL H IS THALIDOMIDE MUTAGENIC | 7 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 561 | 8 | 34 | 1264 1996 HEPATOLOGY 23(6):1616-1621 LopezTalavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ Thalidomide inhibits tumor necrosis factor alpha decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats | 7 | 52 |
| 562 | 11 | 14 | 1270 1996 INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY 111(1):13-17 SantosMendoza T; FavilaCastillo L; Oltra A; Tamariz J; Labarrios F; EstradaParra S; EstradaGarcia I Thalidomide and its metabolites have no effect on human lymphocyte proliferation | 7 | 9 |
| 563 | 7 | 13 | 1388 1997 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 17(1):1-5 Huang PHT; McBride WG Interaction of [glutarimide-2-C-14]-thalidomide with rat embryonic DNA in vivo | 7 | 12 |
| 564 | 7 | 10 | 1454 1998 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 39(2):293-295 Warren KJ; Nopper AJ; Crosby DL Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus | 7 | 9 |
| 565 | 0 | 0 | 1495 1999 ARTHRITIS AND RHEUMATISM 42(10):2259-2260 Gompel A; Frances C; Piette JC; Blanc AS; Cordoliani F; Piette AM Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al | 7 | 8 |
| 566 | 4 | 5 | 1573 1999 LANCET 353(9149):324-324 Klausner JD; Kaplan G; Haslett PAJ Thalidomide in toxic epidermal necrolysis | 7 | 8 |
| 567 | 91 | 116 | 1617 2000 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 127(6-7):603-613 Laffitte E; Revuz J Thalidomide | 7 | 8 |
| 568 | 17 | 32 | 1708 2000 ELECTROPHORESIS 21(15):3270-3279 Meyring M; Muhlenbrock C; Blaschke G Investigation of the stereoselective in vitro biotransformation of thalidomide using a dual cyclodextrin system in capillary electrophoresis | 7 | 16 |
| 569 | 1 | 1 | 1766 2000 NEW ENGLAND JOURNAL OF MEDICINE 342(5):364-364 Singhal S Antitumor activity of thalidomide in refractory multiple myeloma (vol 341, pg 1565, 1999) | 7 | 15 |
| 570 | 2 | 8 | 1777 2000 ONCOLOGY-NEW YORK 14(12):29-32 Govindarajan R Irinotecan and thalidomide in metastatic colorectal cancer | 7 | 12 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 571 | 39 | 60 | 1900 2001 CELLULAR AND MOLECULAR BIOLOGY 47(7):1105-1114 Settles B; Stevenson A; Wilson K; Mack C; Ezell T; Davis MF; Taylor LD Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide | 7 | 10 |
| 572 | 8 | 13 | 1918 2001 DRUG METABOLISM AND DISPOSITION 29(10):1355-1357 Teo SK; Harden JL; Burke AB; Noormohamed FH; Youle M; Johnson MA; Peters BS; Stirling DI; Thomas SD Thalidomide is distributed into human semen after oral dosing | 7 | 12 |
| 573 | 2 | 9 | 1940 2001 HAEMATOLOGICA 86(7):772-773 Pozzato G; Zorat F; Nascimben F; Comar C; Kikic F; Festini G Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia | 7 | 11 |
| 574 | 16 | 24 | 1950 2001 INTERNATIONAL JOURNAL OF CLINICAL PRACTICE 55(9):627-631 Diggle GE Thalidomide: 40 years on | 7 | 9 |
| 575 | 16 | 17 | 2011 2001 SEMINARS IN ONCOLOGY 28(6):602-606 Stirling D Thalidomide: A novel template for anticancer drugs | 7 | 12 |
| 576 | 19 | 48 | 2046 2002 BIOMEDICINE & PHARMACOTHERAPY 56(1):31-35 Shek LPC; Lim DLC Thalidomide in Behcet's disease | 7 | 10 |
| 577 | 30 | 91 | 2049 2002 BIOORGANIC & MEDICINAL CHEMISTRY 10(3):461-479 Hashimoto Y Structural development of biological response modifiers based on thalidomide | 7 | 14 |
| 578 | 1 | 3 | 2059 2002 BLOOD 100(4):1519-1520 Leleu X; Magro L; Fawaz A; Bauters F; Facon T; Yakoub-Agha I Efficacy of a low dose of thalidomide in advanced multiple myeloma | 7 | 7 |
| 579 | 4 | 4 | 2221 2002 JOURNAL OF CLINICAL ONCOLOGY 20(5):1429-1430 Nathan PD; Gore ME; Eisen TG Unexpected toxicity of combination thalidomide and interferon alfa-2a treatment in metastatic renal cell carcinoma | 7 | 11 |
| 580 | 11 | 38 | 2254 2002 LEUKEMIA 16(9):1609-1614 Piccaluga PP; Visani G; Pileri SA; Ascani S; Grafone T; Isidori A; Malagola M; Finelli C; Martinelli G; Ricci P; Baccarani M; Tura S Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study | 7 | 12 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 581 | 7 | 8 | 2256 2002 LEUKEMIA & LYMPHOMA 43(2):351-354 Johnston RE; Abdalla SH Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia | 7 | 9 |
| 582 | 7 | 38 | 2268 2002 MICROBES AND INFECTION 4(11):1193-1202 Teo SK; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD Thalidomide in the treatment of leprosy | 7 | 9 |
| 583 | 18 | 42 | 2340 2003 BLOOD 102(1):69-77 Mileshkin L; Biagi JJ; Mitchell P; Underhill C; Grigg A; Bell R; McKendrick J; Briggs P; Seymour JF; Lillie K; Smith JG; Zeldis JB; Prince HM Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age | 7 | 10 |
| 584 | 8 | 17 | 2515 2003 LEUKEMIA 17(1):41-44 Lentzsch S; LeBlanc R; Podar K; Davies F; Lin B; Hideshima T; Catley L; Stirling DI; Anderson KC Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo | 7 | 16 |
| 585 | 0 | 0 | 37 1961 BRITISH MEDICAL JOURNAL 2(526):1570-& HOWE P NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 6 | 7 |
| 586 | 8 | 14 | 92 1962 CANADIAN MEDICAL ASSOCIATION JOURNAL 87(24):1259-& LING GM; DOLMAN CL; BOYD JR DRUG-INDUCED (THALIDOMIDE) MALFORMATIONS | 6 | 7 |
| 587 | 0 | 0 | 125 1962 LANCET 1(7232):750-& WOODYATT PB THALIDOMIDE | 6 | 8 |
| 588 | 1 | 1 | 148 1962 LANCET 2(7260):836-& HUGHES DT; PLAYFAIR JH; HOPPER PK; DELHANTY JD; CHITHAM RG CHROMOSOMES OF THALIDOMIDE-DEFORMED FOETUSES | 6 | 9 |
| 589 | 4 | 25 | 187 1963 AMERICAN JOURNAL OF PATHOLOGY 43(6):999-& MARINPADILLA M; BENIRSCHKE K THALIDOMIDE INDUCED ALTERATIONS IN BLASTOCYST AND PLACENTA OF ARMADILLO, DASYPUS NOVEMCINCTUS MEXICANUS, INCLUDING A CHORIOCARCINOMA | 6 | 35 |
| 590 | 4 | 14 | 288 1964 LANCET 1(733):724-& FELISATI D TERATOGENIC ACTION OF THALIDOMIDE | 6 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 591 | 3 | 4 | 296 1964 NEW ENGLAND JOURNAL OF MEDICINE 271(9):441-& INGALLS TH; ZAPPASODI P; CURLEY FJ THALIDOMIDE EMBRYOPATHY IN HYPRID RABBITS | 6 | 13 |
| 592 | 4 | 10 | 301 1964 SCIENCE 143(361):1343-& HIRSCHBERG E; BRYANT S; ULTMANN JE; OSNOS M THALIDOMIDE - EFFECTS ON ENZYMES OF GLUTAMIC ACID METABOLISM IN MICE | 6 | 8 |
| 593 | 4 | 7 | 326 1965 CHEMICAL & PHARMACEUTICAL BULLETIN 13(10):1263-& TANAKA A; HASEGAWA A; URAKUBO G METABOLIC FATE OF THALIDOMIDE IN RATS | 6 | 7 |
| 594 | 1 | 7 | 354 1965 PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON 58(7):497-& WOOLLAM DHM PRINCIPLES OF TERATOGENESIS - MODE OF ACTION OF THALIDOMIDE | 6 | 12 |
| 595 | 9 | 18 | 408 1966 SCIENCE 153(3733):310-& FOX RR; SAWIN PB; CRARY DD; WUEST HM INTRAVENOUS INJECTION OF THALIDOMIDE IN PREGNANT RABBITS | 6 | 7 |
| 596 | 17 | 29 | 436 1967 JOURNAL OF PHARMACY AND PHARMACOLOGY 19(9):603-& HAGUE DE; FABRO S; SMITH RL FATE OF [14C]THALIDOMIDE IN PREGNANT HAMSTER | 6 | 8 |
| 597 | 6 | 18 | 451 1968 ARZNEIMITTEL-FORSCHUNG 18(10):1313-& BRODE E EXPERIMENTAL STUDIES ON CYCLIC IMIDES .4. CLEAVING OF PHTHALIMIDE RING IN THALIDOMIDE BY AMINES | 6 | 10 |
| 598 | 3 | 28 | 472 1968 TERATOLOGY 1(3):235-& GLOBUS M; GIBSON MA A HISTOLOGICAL AND HISTOCHEMICAL STUDY OF DEVELOPMENT OF STERNUM IN THALIDOMIDE-TREATED RATS | 6 | 18 |
| 599 | 3 | 18 | 508 1970 MIKROCHIMICA ACTA (3):530-& PISCHEK G; KAISER E; KOCH H THIN-LAYER CHROMATOGRAPHY OF THALIDOMIDE AND ITS HYDROLYSIS PRODUCTS | 6 | 12 |
| 600 | 7 | 13 | 523 1971 EXPERIENTIA 27(10):1149-& KOHLER F; MEISE W; OCKENFEL.H TERATOLOGICAL TESTING OF SOME THALIDOMIDE METABOLITES | 6 | 17 |
Page 2: 1 2 3 4 5 6 7 8 9
Generated by: HistCite(Vlad).
Version: 2004.09.22